Class 4 medicine recallMedicine · 15 Dec 2020
Fairmed Healthcare GmbH has informed us of a discrepancy on the product packaging for some batches. The discrepancy relates to the incorrect spelling of one of the active pharmaceutical ingredients printed on one side…
Class 4 medicine recallMedicine · 14 Dec 2020
Generics [UK] Limited t/a Mylan have informed us that the Patient Information Leaflet (PIL) within the packs for the products listed above is missing relevant important safety information.
Class 4 medicine recallMedicine · 9 Nov 2020
Intrapharm Laboratories Ltd has informed us that there is a difference in dosage instructions between the carton and label. The Patient Information Leaflet (PIL) and bottle label contain the correct instructions.
Class 4 medicine recallMedicine · 10 Sep 2020
Ratiopharm UK Limited and Generics [UK] Limited t/a Mylan have confirmed that the Patient Information Leaflet (PIL) within all packs and the Summary of Product Characteristics (SmPC) for Ratiopharm is missing important safety information…
Class 4 medicine recallMedicine · 1 Sep 2020
The MHRA is currently investigating an incident where several medicines appear to have left the legal supply chain and have then been re-introduced via Kingsley Specials Ltd WDA(H) 49276, who purchased from a company…
Class 4 medicine recallMedicine · 13 Aug 2020
Fresenius Kabi Ltd & Calea UK Ltd has informed us of an error on the bag labels for SmofKabiven extra nitrogen electrolyte free, emulsion for infusion PL 08828/0269.
Class 4 medicine recallMedicine · 23 Jul 2020
Pfizer Limited has informed us that the packs for the affected batches below have not been packaged with the current version of the Patient Information Leaflet (PIL) containing updated storage instructions of the infusion…
Class 4 medicine recallMedicine · 20 Jul 2020
Ennogen Pharma Limited has informed us that the Patient Information Leaflets (PILs) within the packs for the affected batches below contain an error in Section 3 (How To Take Trimogal Tablets) with regard to…
Class 4 medicine recallMedicine · 20 Jul 2020
Aspar Pharmaceuticals Limited has informed us that the Patient Information Leaflets (PILs) within the ibuprofen packs below are missing some information identified from post-marketing experience that should be documented in Section 3 (How To…
Class 4 medicine recallMedicine · 30 Jun 2020
Drugsrus Ltd (distributor) / Tenolol Ltd (MA Holder) has informed us of a typographical error in active ingredient stated on the label on the vial.
Class 4 medicine recallMedicine · 28 May 2020
Torbay Pharmaceuticals has informed us that the carton label on Sodium Benzoate (Amzoate) 2g in 10 mL Sterile Solution for injection incorrectly states the concentration of disodium edetate (excipient) as 0.1% w/v (10mg in…
Class 4 medicine recallMedicine · 20 Apr 2020
GSK has informed us that due to a machinery defect with the printing line, a small number of packs may not have the batch number and expiry date printed on the outer cartons. The…
Class 4 medicine recallMedicine · 16 Apr 2020
TEVA UK Limited has informed us that the Product Code/GTIN (PC) number found on the below batches is incorrect.
Class 4 medicine recallMedicine · 30 Mar 2020
Rosemont Pharmaceuticals Ltd has informed us of an error in the barcode and GTIN number of the label on the bottle of the below batches.
Class 4 medicine recallMedicine · 19 Mar 2020
The MHRA is currently investigating an incident where several medicines appear to have left the legal supply chain and have then been re-introduced via WDA(H) 50340 HMS Wholesale Limited. This License has now been…
Class 4 medicine recallMedicine · 11 Mar 2020
Mylan UK Healthcare Ltd has informed us that a product complaint has been received relating to crystalline precipitate being observed during bottle use. Due to concerns with continuity of supply these batches are not…
Class 4 medicine recallMedicine · 27 Feb 2020
G.L Pharma GmbH T/A Healthcare Pharma Ltd has informed us that the Patient Information Leaflet (PIL) within the packs for the specified batches is missing important safety relevant text changes.
Class 4 medicine recallMedicine · 25 Feb 2020
Crescent Pharma Ltd has informed us of a discrepancy on the product packaging.
Class 4 medicine recallMedicine · 24 Feb 2020
Crescent Pharma Ltd and Flamingo Pharma (UK) Ltd have informed us that the Patient Information Leaflet (PIL) within their packs for the above pharmacy (P) batches is incorrect.
Class 4 medicine recallMedicine · 17 Feb 2020
Accord Healthcare Ltd has informed us of an issue related to the expiry date for the above batches, which has not been encoded in 2D data matrix.
Class 4 medicine recallMedicine · 12 Feb 2020
Accord Healthcare Ltd has informed us that the Patient Information Leaflet (PIL) for all strengths of Atrolak XL Prolonged-release tablets is missing the side effects identified from post-marketing experience.
Class 4 medicine recallMedicine · 29 Jan 2020
Dr Reddy's Laboratories (UK) Ltd has informed us that the Patient Information Leaflet (PIL) for the specific batches listed in this alert are missing the special warning and precautions identified from post-marketing experience that…
Class 4 medicine recallMedicine · 14 Jan 2020
Caution in Use: Distribute to Pharmacy level. Advanz Pharma has informed us of a discrepancy on the product packaging. The discrepancy relates to “capsules” printed at the top right of the packs in error,…
Class 4 medicine recallMedicine · 16 Oct 2019
Alliance Pharmaceuticals Ltd has informed the MHRA that there are possible side effects not reported on the Patient Information Leaflet.